Sun Y, Wang X, Chen W-M, Hao Y, Di Li L-, Li J-Y, Sun K, Shi Z-Y, Jiang H, Jiang Q, et al. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia. Hematol Oncol. 2024;42(2):e3264. Google ScholarPubMedLog in or register to post comments